HDFC Pharma and Healthcare Fund Direct Growth
Get the latest NAV of HDFC Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹16.41
NAV as on 16 May 2025
36.15%/per year
Since Inception
▲▼
11054 people have invested ₹ 3.4Cr in HDFC Pharma and Healthcare Fund Direct Growth in the last three months
HDFC Pharma and Healthcare Fund Performance vs. Nifty 500
Fund returns vs Benchmark returns vs Category Average returns as on (16-May-25)
The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
HDFC Pharma and Healthcare Fund Returns Calculator
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
HDFC Pharma and Healthcare Fund Asset Allocation
See fund asset allocation details as on (13-May-25)
Fund Distribution
as on (13-May-25)
Equity 97.2%
Debt & Cash 1.6%
HDFC Pharma and Healthcare Fund Sector Allocation
See fund sector allocation details as on (13-May-25)
Sector Allocation
Equity 97.2%
Debt & Cash 1.6%
Top 3 Sectors in April were Health, Corporate & Basic Materials
Health
98%
Corporate
38%
Basic Materials
2%
Health
98%
Corporate
35%
Basic Materials
2%
HDFC Pharma and Healthcare Fund Holdings Details
as on (30-Apr-25)
Equity
HDFC Pharma and Healthcare Fund Direct Growth Overview
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
| Expense ratio | 0.94% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹1666 Cr |
| Inception Date | 4 October, 2023 |
| Min Lumpsum/SIP | ₹100/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 28.39% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
About HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 4 October, 2023. The fund is managed by . The fund could potentially beat inflation in the long-run.
Key Parameters
- HDFC Pharma and Healthcare Fund Direct Growth has ₹1666 Cr worth of assets under management (AUM) as on Apr 2025 and is less than category average.
- The fund has an expense ratio 0.9.
Returns
HDFC Pharma and Healthcare Fund Direct Growth has given a CAGR return of 36.15% since inception. Over the last 1 year the fund has given a CAGR return of 28.19%.
Holdings
HDFC Pharma and Healthcare Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent, Corporate, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Cipla Ltd, Lupin Ltd, Max Healthcare Institute Ltd Ordinary Shares
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of HDFC Pharma and Healthcare Fund Direct Growth
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. HDFC Pharma and Healthcare Fund Direct Growth has no lock in period.
- AUM of the fund stands at 1.6K Cr as of Apr'25
- AUM has remained same between Apr'25 and Mar'25
More funds from HDFC
5Y CAGR
▲ 38.80
5Y CAGR
▲ 33.86
5Y CAGR
▲ 33.26
3Y CAGR
▲ 28.03
Frequently Asked Questions for HDFC Pharma and Healthcare Fund Direct Growth
What is the current NAV of HDFC Pharma and Healthcare Fund Direct Growth?
What are the average returns of HDFC Pharma and Healthcare Fund Direct Growth?
HDFC Pharma and Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 2.63% | 2.63% |
6 Month Returns | 2.01% | 2.01% |
1 Year Returns | 28.19% | 28.19% |
3 Years Returns | 0% | 0% |
How do I invest in HDFC Pharma and Healthcare Fund Direct Growth?
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
What is the expense ratio of HDFC Pharma and Healthcare Fund Direct Growth?
What is net assets under management (AUM) of HDFC Pharma and Healthcare Fund Direct Growth?
What are the top 5 holdings of HDFC Pharma and Healthcare Fund Direct Growth?
What is the alpha of HDFC Pharma and Healthcare Fund Direct Growth?
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
HDFC Pharma and Healthcare Fund Direct Growth | 7.78 | - | - |
What is the beta of HDFC Pharma and Healthcare Fund Direct Growth??
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
HDFC Pharma and Healthcare Fund Direct Growth | 1 | - | - |
What is the sharpe ratio of HDFC Pharma and Healthcare Fund Direct Growth?
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
HDFC Pharma and Healthcare Fund Direct Growth | 1.04 | - | - |
What is the standard deviation of HDFC Pharma and Healthcare Fund Direct Growth?
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
HDFC Pharma and Healthcare Fund Direct Growth | 20.35 | - | - |